Global Age Related Macular Degeneration Treatment Market Growth 2019-2024

January 2019 | 135 pages | ID: G2150DD5926EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.

According to this study, over the next five years the Age Related Macular Degeneration Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Age Related Macular Degeneration Treatment business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Age Related Macular Degeneration Treatment market by product type, application, key manufacturers and key regions and countries.

This study considers the Age Related Macular Degeneration Treatment value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

• Lucentis
• Eylea
• Avastin
• Other

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

• Hospital
• Clinic
• Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

• Regeneron Pharmaceuticals
• Bayer HealthCare
• Novartis
• Roche
• Kanghong Pharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Age Related Macular Degeneration Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
• To understand the structure of Age Related Macular Degeneration Treatment market by identifying its various subsegments.
• Focuses on the key global Age Related Macular Degeneration Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Age Related Macular Degeneration Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Age Related Macular Degeneration Treatment submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2019-2024 GLOBAL AGE RELATED MACULAR DEGENERATION TREATMENT CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Age Related Macular Degeneration Treatment Consumption 2014-2024
  2.1.2 Age Related Macular Degeneration Treatment Consumption CAGR by Region
2.2 Age Related Macular Degeneration Treatment Segment by Type
  2.2.1 Lucentis
  2.2.2 Eylea
  2.2.3 Avastin
  2.2.4 Other
2.3 Age Related Macular Degeneration Treatment Consumption by Type
  2.3.1 Global Age Related Macular Degeneration Treatment Consumption Market Share by Type (2014-2019)
  2.3.2 Global Age Related Macular Degeneration Treatment Revenue and Market Share by Type (2014-2019)
  2.3.3 Global Age Related Macular Degeneration Treatment Sale Price by Type (2014-2019)
2.4 Age Related Macular Degeneration Treatment Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Other
2.5 Age Related Macular Degeneration Treatment Consumption by Application
  2.5.1 Global Age Related Macular Degeneration Treatment Consumption Market Share by Application (2014-2019)
  2.5.2 Global Age Related Macular Degeneration Treatment Value and Market Share by Application (2014-2019)
  2.5.3 Global Age Related Macular Degeneration Treatment Sale Price by Application (2014-2019)

3 GLOBAL AGE RELATED MACULAR DEGENERATION TREATMENT BY PLAYERS

3.1 Global Age Related Macular Degeneration Treatment Sales Market Share by Players
  3.1.1 Global Age Related Macular Degeneration Treatment Sales by Players (2017-2019)
  3.1.2 Global Age Related Macular Degeneration Treatment Sales Market Share by Players (2017-2019)
3.2 Global Age Related Macular Degeneration Treatment Revenue Market Share by Players
  3.2.1 Global Age Related Macular Degeneration Treatment Revenue by Players (2017-2019)
  3.2.2 Global Age Related Macular Degeneration Treatment Revenue Market Share by Players (2017-2019)
3.3 Global Age Related Macular Degeneration Treatment Sale Price by Players
3.4 Global Age Related Macular Degeneration Treatment Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Age Related Macular Degeneration Treatment Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Age Related Macular Degeneration Treatment Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 AGE RELATED MACULAR DEGENERATION TREATMENT BY REGIONS

4.1 Age Related Macular Degeneration Treatment by Regions
  4.1.1 Global Age Related Macular Degeneration Treatment Consumption by Regions
  4.1.2 Global Age Related Macular Degeneration Treatment Value by Regions
4.2 Americas Age Related Macular Degeneration Treatment Consumption Growth
4.3 APAC Age Related Macular Degeneration Treatment Consumption Growth
4.4 Europe Age Related Macular Degeneration Treatment Consumption Growth
4.5 Middle East & Africa Age Related Macular Degeneration Treatment Consumption Growth

5 AMERICAS

5.1 Americas Age Related Macular Degeneration Treatment Consumption by Countries
  5.1.1 Americas Age Related Macular Degeneration Treatment Consumption by Countries (2014-2019)
  5.1.2 Americas Age Related Macular Degeneration Treatment Value by Countries (2014-2019)
5.2 Americas Age Related Macular Degeneration Treatment Consumption by Type
5.3 Americas Age Related Macular Degeneration Treatment Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Age Related Macular Degeneration Treatment Consumption by Countries
  6.1.1 APAC Age Related Macular Degeneration Treatment Consumption by Countries (2014-2019)
  6.1.2 APAC Age Related Macular Degeneration Treatment Value by Countries (2014-2019)
6.2 APAC Age Related Macular Degeneration Treatment Consumption by Type
6.3 APAC Age Related Macular Degeneration Treatment Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Age Related Macular Degeneration Treatment by Countries
  7.1.1 Europe Age Related Macular Degeneration Treatment Consumption by Countries (2014-2019)
  7.1.2 Europe Age Related Macular Degeneration Treatment Value by Countries (2014-2019)
7.2 Europe Age Related Macular Degeneration Treatment Consumption by Type
7.3 Europe Age Related Macular Degeneration Treatment Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Age Related Macular Degeneration Treatment by Countries
  8.1.1 Middle East & Africa Age Related Macular Degeneration Treatment Consumption by Countries (2014-2019)
  8.1.2 Middle East & Africa Age Related Macular Degeneration Treatment Value by Countries (2014-2019)
8.2 Middle East & Africa Age Related Macular Degeneration Treatment Consumption by Type
8.3 Middle East & Africa Age Related Macular Degeneration Treatment Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Channels
  10.1.2 Indirect Channels
10.2 Age Related Macular Degeneration Treatment Distributors
10.3 Age Related Macular Degeneration Treatment Customer

11 GLOBAL AGE RELATED MACULAR DEGENERATION TREATMENT MARKET FORECAST

11.1 Global Age Related Macular Degeneration Treatment Consumption Forecast (2019-2024)
11.2 Global Age Related Macular Degeneration Treatment Forecast by Regions
  11.2.1 Global Age Related Macular Degeneration Treatment Forecast by Regions (2019-2024)
  11.2.2 Global Age Related Macular Degeneration Treatment Value Forecast by Regions (2019-2024)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Age Related Macular Degeneration Treatment Forecast by Type
11.8 Global Age Related Macular Degeneration Treatment Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Regeneron Pharmaceuticals
  12.1.1 Company Details
  12.1.2 Age Related Macular Degeneration Treatment Product Offered
  12.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
  12.1.4 Main Business Overview
  12.1.5 Regeneron Pharmaceuticals News
12.2 Bayer HealthCare
  12.2.1 Company Details
  12.2.2 Age Related Macular Degeneration Treatment Product Offered
  12.2.3 Bayer HealthCare Age Related Macular Degeneration Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
  12.2.4 Main Business Overview
  12.2.5 Bayer HealthCare News
12.3 Novartis
  12.3.1 Company Details
  12.3.2 Age Related Macular Degeneration Treatment Product Offered
  12.3.3 Novartis Age Related Macular Degeneration Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
  12.3.4 Main Business Overview
  12.3.5 Novartis News
12.4 Roche
  12.4.1 Company Details
  12.4.2 Age Related Macular Degeneration Treatment Product Offered
  12.4.3 Roche Age Related Macular Degeneration Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
  12.4.4 Main Business Overview
  12.4.5 Roche News
12.5 Kanghong Pharma
  12.5.1 Company Details
  12.5.2 Age Related Macular Degeneration Treatment Product Offered
  12.5.3 Kanghong Pharma Age Related Macular Degeneration Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
  12.5.4 Main Business Overview
  12.5.5 Kanghong Pharma News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Age Related Macular Degeneration Treatment
Table Product Specifications of Age Related Macular Degeneration Treatment
Figure Age Related Macular Degeneration Treatment Report Years Considered
Figure Market Research Methodology
Figure Global Age Related Macular Degeneration Treatment Consumption Growth Rate 2014-2024 (K Units)
Figure Global Age Related Macular Degeneration Treatment Value Growth Rate 2014-2024 ($ Millions)
Table Age Related Macular Degeneration Treatment Consumption CAGR by Region 2014-2024 ($ Millions)
Figure Product Picture of Lucentis
Table Major Players of Lucentis
Figure Product Picture of Eylea
Table Major Players of Eylea
Figure Product Picture of Avastin
Table Major Players of Avastin
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2014-2019)
Table Global Age Related Macular Degeneration Treatment Consumption Market Share by Type (2014-2019)
Figure Global Age Related Macular Degeneration Treatment Consumption Market Share by Type (2014-2019)
Table Global Age Related Macular Degeneration Treatment Revenue by Type (2014-2019) ($ million)
Table Global Age Related Macular Degeneration Treatment Value Market Share by Type (2014-2019) ($ Millions)
Figure Global Age Related Macular Degeneration Treatment Value Market Share by Type (2014-2019)
Table Global Age Related Macular Degeneration Treatment Sale Price by Type (2014-2019)
Figure Age Related Macular Degeneration Treatment Consumed in Hospital
Figure Global Age Related Macular Degeneration Treatment Market: Hospital (2014-2019) (K Units)
Figure Global Age Related Macular Degeneration Treatment Market: Hospital (2014-2019) ($ Millions)
Figure Global Hospital YoY Growth ($ Millions)
Figure Age Related Macular Degeneration Treatment Consumed in Clinic
Figure Global Age Related Macular Degeneration Treatment Market: Clinic (2014-2019) (K Units)
Figure Global Age Related Macular Degeneration Treatment Market: Clinic (2014-2019) ($ Millions)
Figure Global Clinic YoY Growth ($ Millions)
Figure Age Related Macular Degeneration Treatment Consumed in Other
Figure Global Age Related Macular Degeneration Treatment Market: Other (2014-2019) (K Units)
Figure Global Age Related Macular Degeneration Treatment Market: Other (2014-2019) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2014-2019)
Table Global Age Related Macular Degeneration Treatment Consumption Market Share by Application (2014-2019)
Figure Global Age Related Macular Degeneration Treatment Consumption Market Share by Application (2014-2019)
Table Global Age Related Macular Degeneration Treatment Value by Application (2014-2019)
Table Global Age Related Macular Degeneration Treatment Value Market Share by Application (2014-2019)
Figure Global Age Related Macular Degeneration Treatment Value Market Share by Application (2014-2019)
Table Global Age Related Macular Degeneration Treatment Sale Price by Application (2014-2019)
Table Global Age Related Macular Degeneration Treatment Sales by Players (2017-2019) (K Units)
Table Global Age Related Macular Degeneration Treatment Sales Market Share by Players (2017-2019)
Figure Global Age Related Macular Degeneration Treatment Sales Market Share by Players in 2017
Figure Global Age Related Macular Degeneration Treatment Sales Market Share by Players in 2018
Table Global Age Related Macular Degeneration Treatment Revenue by Players (2017-2019) ($ Millions)
Table Global Age Related Macular Degeneration Treatment Revenue Market Share by Players (2017-2019)
Figure Global Age Related Macular Degeneration Treatment Revenue Market Share by Players in 2017
Figure Global Age Related Macular Degeneration Treatment Revenue Market Share by Players in 2018
Table Global Age Related Macular Degeneration Treatment Sale Price by Players (2017-2019)
Figure Global Age Related Macular Degeneration Treatment Sale Price by Players in 2018
Table Global Age Related Macular Degeneration Treatment Manufacturing Base Distribution and Sales Area by Players
Table Players Age Related Macular Degeneration Treatment Products Offered
Table Age Related Macular Degeneration Treatment Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Age Related Macular Degeneration Treatment Consumption by Regions 2014-2019 (K Units)
Table Global Age Related Macular Degeneration Treatment Consumption Market Share by Regions 2014-2019
Figure Global Age Related Macular Degeneration Treatment Consumption Market Share by Regions 2014-2019
Table Global Age Related Macular Degeneration Treatment Value by Regions 2014-2019 ($ Millions)
Table Global Age Related Macular Degeneration Treatment Value Market Share by Regions 2014-2019
Figure Global Age Related Macular Degeneration Treatment Value Market Share by Regions 2014-2019
Figure Americas Age Related Macular Degeneration Treatment Consumption 2014-2019 (K Units)
Figure Americas Age Related Macular Degeneration Treatment Value 2014-2019 ($ Millions)
Figure APAC Age Related Macular Degeneration Treatment Consumption 2014-2019 (K Units)
Figure APAC Age Related Macular Degeneration Treatment Value 2014-2019 ($ Millions)
Figure Europe Age Related Macular Degeneration Treatment Consumption 2014-2019 (K Units)
Figure Europe Age Related Macular Degeneration Treatment Value 2014-2019 ($ Millions)
Figure Middle East & Africa Age Related Macular Degeneration Treatment Consumption 2014-2019 (K Units)
Figure Middle East & Africa Age Related Macular Degeneration Treatment Value 2014-2019 ($ Millions)
Table Americas Age Related Macular Degeneration Treatment Consumption by Countries (2014-2019) (K Units)
Table Americas Age Related Macular Degeneration Treatment Consumption Market Share by Countries (2014-2019)
Figure Americas Age Related Macular Degeneration Treatment Consumption Market Share by Countries in 2018
Table Americas Age Related Macular Degeneration Treatment Value by Countries (2014-2019) ($ Millions)
Table Americas Age Related Macular Degeneration Treatment Value Market Share by Countries (2014-2019)
Figure Americas Age Related Macular Degeneration Treatment Value Market Share by Countries in 2018
Table Americas Age Related Macular Degeneration Treatment Consumption by Type (2014-2019) (K Units)
Table Americas Age Related Macular Degeneration Treatment Consumption Market Share by Type (2014-2019)
Figure Americas Age Related Macular Degeneration Treatment Consumption Market Share by Type in 2018
Table Americas Age Related Macular Degeneration Treatment Consumption by Application (2014-2019) (K Units)
Table Americas Age Related Macular Degeneration Treatment Consumption Market Share by Application (2014-2019)
Figure Americas Age Related Macular Degeneration Treatment Consumption Market Share by Application in 2018
Figure United States Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure United States Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Figure Canada Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure Canada Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Figure Mexico Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure Mexico Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Table APAC Age Related Macular Degeneration Treatment Consumption by Countries (2014-2019) (K Units)
Table APAC Age Related Macular Degeneration Treatment Consumption Market Share by Countries (2014-2019)
Figure APAC Age Related Macular Degeneration Treatment Consumption Market Share by Countries in 2018
Table APAC Age Related Macular Degeneration Treatment Value by Countries (2014-2019) ($ Millions)
Table APAC Age Related Macular Degeneration Treatment Value Market Share by Countries (2014-2019)
Figure APAC Age Related Macular Degeneration Treatment Value Market Share by Countries in 2018
Table APAC Age Related Macular Degeneration Treatment Consumption by Type (2014-2019) (K Units)
Table APAC Age Related Macular Degeneration Treatment Consumption Market Share by Type (2014-2019)
Figure APAC Age Related Macular Degeneration Treatment Consumption Market Share by Type in 2018
Table APAC Age Related Macular Degeneration Treatment Consumption by Application (2014-2019) (K Units)
Table APAC Age Related Macular Degeneration Treatment Consumption Market Share by Application (2014-2019)
Figure APAC Age Related Macular Degeneration Treatment Consumption Market Share by Application in 2018
Figure China Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure China Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Figure Japan Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure Japan Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Figure Korea Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure Korea Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Figure Southeast Asia Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure Southeast Asia Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Figure India Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure India Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Figure Australia Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure Australia Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Table Europe Age Related Macular Degeneration Treatment Consumption by Countries (2014-2019) (K Units)
Table Europe Age Related Macular Degeneration Treatment Consumption Market Share by Countries (2014-2019)
Figure Europe Age Related Macular Degeneration Treatment Consumption Market Share by Countries in 2018
Table Europe Age Related Macular Degeneration Treatment Value by Countries (2014-2019) ($ Millions)
Table Europe Age Related Macular Degeneration Treatment Value Market Share by Countries (2014-2019)
Figure Europe Age Related Macular Degeneration Treatment Value Market Share by Countries in 2018
Table Europe Age Related Macular Degeneration Treatment Consumption by Type (2014-2019) (K Units)
Table Europe Age Related Macular Degeneration Treatment Consumption Market Share by Type (2014-2019)
Figure Europe Age Related Macular Degeneration Treatment Consumption Market Share by Type in 2018
Table Europe Age Related Macular Degeneration Treatment Consumption by Application (2014-2019) (K Units)
Table Europe Age Related Macular Degeneration Treatment Consumption Market Share by Application (2014-2019)
Figure Europe Age Related Macular Degeneration Treatment Consumption Market Share by Application in 2018
Figure Germany Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure Germany Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Figure France Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure France Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Figure UK Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure UK Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Figure Italy Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure Italy Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Figure Russia Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure Russia Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Figure Spain Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure Spain Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Table Middle East & Africa Age Related Macular Degeneration Treatment Consumption by Countries (2014-2019) (K Units)
Table Middle East & Africa Age Related Macular Degeneration Treatment Consumption Market Share by Countries (2014-2019)
Figure Middle East & Africa Age Related Macular Degeneration Treatment Consumption Market Share by Countries in 2018
Table Middle East & Africa Age Related Macular Degeneration Treatment Value by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Age Related Macular Degeneration Treatment Value Market Share by Countries (2014-2019)
Figure Middle East & Africa Age Related Macular Degeneration Treatment Value Market Share by Countries in 2018
Table Middle East & Africa Age Related Macular Degeneration Treatment Consumption by Type (2014-2019) (K Units)
Table Middle East & Africa Age Related Macular Degeneration Treatment Consumption Market Share by Type (2014-2019)
Figure Middle East & Africa Age Related Macular Degeneration Treatment Consumption Market Share by Type in 2018
Table Middle East & Africa Age Related Macular Degeneration Treatment Consumption by Application (2014-2019) (K Units)
Table Middle East & Africa Age Related Macular Degeneration Treatment Consumption Market Share by Application (2014-2019)
Figure Middle East & Africa Age Related Macular Degeneration Treatment Consumption Market Share by Application in 2018
Figure Egypt Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure Egypt Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Figure South Africa Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure South Africa Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Figure Israel Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure Israel Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Figure Turkey Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure Turkey Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Figure GCC Countries Age Related Macular Degeneration Treatment Consumption Growth 2014-2019 (K Units)
Figure GCC Countries Age Related Macular Degeneration Treatment Value Growth 2014-2019 ($ Millions)
Table Age Related Macular Degeneration Treatment Distributors List
Table Age Related Macular Degeneration Treatment Customer List
Figure Global Age Related Macular Degeneration Treatment Consumption Growth Rate Forecast (2019-2024) (K Units)
Figure Global Age Related Macular Degeneration Treatment Value Growth Rate Forecast (2019-2024) ($ Millions)
Table Global Age Related Macular Degeneration Treatment Consumption Forecast by Countries (2019-2024) (K Units)
Table Global Age Related Macular Degeneration Treatment Consumption Market Forecast by Regions
Table Global Age Related Macular Degeneration Treatment Value Forecast by Countries (2019-2024) ($ Millions)
Table Global Age Related Macular Degeneration Treatment Value Market Share Forecast by Regions
Figure Americas Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure Americas Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure APAC Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure APAC Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure Europe Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure Europe Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure Middle East & Africa Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure Middle East & Africa Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure United States Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure United States Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure Canada Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure Canada Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure Mexico Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure Mexico Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure Brazil Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure Brazil Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure China Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure China Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure Japan Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure Japan Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure Korea Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure Korea Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure Southeast Asia Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure Southeast Asia Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure India Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure India Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure Australia Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure Australia Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure Germany Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure Germany Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure France Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure France Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure UK Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure UK Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure Italy Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure Italy Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure Russia Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure Russia Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure Spain Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure Spain Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure Egypt Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure Egypt Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure South Africa Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure South Africa Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure Israel Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure Israel Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure Turkey Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure Turkey Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Figure GCC Countries Age Related Macular Degeneration Treatment Consumption 2019-2024 (K Units)
Figure GCC Countries Age Related Macular Degeneration Treatment Value 2019-2024 ($ Millions)
Table Global Age Related Macular Degeneration Treatment Consumption Forecast by Type (2019-2024) (K Units)
Table Global Age Related Macular Degeneration Treatment Consumption Market Share Forecast by Type (2019-2024)
Table Global Age Related Macular Degeneration Treatment Value Forecast by Type (2019-2024) ($ Millions)
Table Global Age Related Macular Degeneration Treatment Value Market Share Forecast by Type (2019-2024)
Table Global Age Related Macular Degeneration Treatment Consumption Forecast by Application (2019-2024) (K Units)
Table Global Age Related Macular Degeneration Treatment Consumption Market Share Forecast by Application (2019-2024)
Table Global Age Related Macular Degeneration Treatment Value Forecast by Application (2019-2024) ($ Millions)
Table Global Age Related Macular Degeneration Treatment Value Market Share Forecast by Application (2019-2024)
Table Regeneron Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Market Share (2017-2019)
Table Bayer HealthCare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer HealthCare Age Related Macular Degeneration Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Bayer HealthCare Age Related Macular Degeneration Treatment Market Share (2017-2019)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Age Related Macular Degeneration Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Novartis Age Related Macular Degeneration Treatment Market Share (2017-2019)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Age Related Macular Degeneration Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Roche Age Related Macular Degeneration Treatment Market Share (2017-2019)
Table Kanghong Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kanghong Pharma Age Related Macular Degeneration Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Kanghong Pharma Age Related Macular Degeneration Treatment Market Share (2017-2019)